Epidemiological and clinical features of malignant hyperthermia: A scoping review
Clinical Genetics · 2024-03 · 105 (3) · 233-242
DOI: 10.1111/cge.14475 ↗Kurz gefasst
Scoping Review in der Zeitschrift Clinical Genetics, online erschienen am 26.12.2023. Verfasst von Zhukai Cong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Malignant Hyperthermia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Medicine Plus X-Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Malignant hyperthermia (MH) is a potentially fatal inherited pharmacogenetic disorder related to pathogenic variants in the RYR1 , CACNA1S , or STAC3 genes. Early recognition of the occurrence of MH and prompt medical treatment are indispensable to ensure a positive outcome. The purpose of this study was to provide valuable information for the early identification of MH by summarizing epidemiological and clinical features of MH. This scoping review followed the methodological framework recommended by Arksey and O'Malley. PubMed, Embase, and Web of science databases were searched for studies that evaluated the epidemical and clinical characteristics of MH. A total of 37 studies were included in this review, of which 26 were related to epidemiology and 24 were associated with clinical characteristics. The morbidity of MH varied from 0.18 per 100 000 to 3.9 per 100 000. The mortality was within the range of 0%–18.2%. Identified risk factors included sex, age, disorders associated with MH, and others. The most frequent initial clinical signs included hyperthermia, sinus tachycardia, and hypercarbia. The occurrence of certain signs, such as hypercapnia, delayed first temperature measurement, and peak temperature were associated with poor outcomes. The epidemiological and clinical features of MH varied considerably and some risk factors and typical clinical signs were identified. The main limitation of this review is that the treatment and management strategies were not assessed sufficiently due to limited information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Peking University Third Hospital, Beijing, China.
- Beijing Center of Quality Control and lmprovement on Clinical Anesthesia, Beijing, China.
- Department of Anesthesiology, MedStar Washington Hospital Center, Washington, DC, USA.
- Research Center for Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Clinical Medicine Plus X-Young Scholars Project, Peking University, the Fundamental Research Funds for the Central Universities
Zitieren
APA
Cong, Z., Wan, T., Wang, J., Feng, L., Cao, C., Li, Z., Wang, X., Han, Y., Zhou, Y., Gao, Y., Zhang, J., Qu, Y., & Guo, X. (2024). Epidemiological and clinical features of malignant hyperthermia: A scoping review. Clinical Genetics, 105(3), 233-242. https://doi.org/10.1111/cge.14475
Vancouver
Cong Z, Wan T, Wang J, Feng L, Cao C, Li Z, et al. Epidemiological and clinical features of malignant hyperthermia: A scoping review. Clinical Genetics. 2024;105(3):233-242. doi:10.1111/cge.14475
BibTeX
@article{Cong2024,
author = {Cong, Zhukai and Wan, Tingting and Wang, Jiechu and Feng, Luyang and Cao, Cathy and Li, Zhengqian and Wang, Xiaoxiao and Han, Yongzheng and Zhou, Yang and Gao, Ya and Zhang, Jing and Qu, Yinyin and Guo, Xiangyang},
title = {Epidemiological and clinical features of malignant hyperthermia: A scoping review},
journal = {Clinical Genetics},
year = {2024},
volume = {105},
number = {3},
pages = {233--242},
doi = {10.1111/cge.14475}
}
EUVIMED